MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.

Slides:



Advertisements
Similar presentations
Volume 342, Issue 1, Pages (January 2014)
Advertisements

Fig. 1 Increased MIR155HG expression correlates with glioma grade and mesenchymal transition and confers a poor prognosis in GBM patients. (A) The level.
Molecular Therapy - Nucleic Acids
Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a Cell Physiol Biochem.
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
Cell Physiol Biochem 2017;44:1867– DOI: /
Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma  Kuang-Tzu Huang, I-Ying Kuo, Ming-Chao.
Volume 68, Issue 1, Pages e6 (October 2017)
Molecular Therapy - Nucleic Acids
Volume 144, Issue 3, Pages e4 (March 2013)
Volume 145, Issue 4, Pages e9 (October 2013)
Integrin αvβ6 Promotes Lung Cancer Proliferation and Metastasis through Upregulation of IL-8–Mediated MAPK/ERK Signaling  Pengwei Yan, Huanfeng Zhu, Li.
WT1 Promotes Invasion of NSCLC via Suppression of CDH1
Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis  Ruo-Chia Tseng, PhD, Jia-Ming Chang,
Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.
Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT  Zhen-Yu He, San-Gang Wu, Fang Peng,
IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling  Yuan-Hua Xu, Zheng-Li Li,
MicroRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7  Yixiong Lin, Jianjun Liu, Yuqi Huang,
Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC  Guanming Jiao, Qi Huang, Muren Hu, Xuchun Liang, Fuchen Li, Chunling.
Volume 145, Issue 4, Pages e9 (October 2013)
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Molecular Therapy - Nucleic Acids
Volume 68, Issue 1, Pages e6 (October 2017)
Volume 19, Issue 3, Pages (March 2017)
Volume 20, Issue 2, Pages (February 2018)
Volume 5, Issue 6, Pages (December 2013)
Uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non- Small-Cell Lung Cancer  Jun Zhou, Chenghai Wang, Weijuan Gong, Yandan.
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Volume 63, Issue 6, Pages (September 2016)
A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance  Ji-Hak.
Molecular Therapy - Nucleic Acids
Volume 25, Issue 3, Pages (March 2017)
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Volume 25, Issue 9, Pages (September 2017)
Molecular Therapy - Nucleic Acids
Volume 21, Issue 12, Pages (December 2017)
MiR-135b Stimulates Osteosarcoma Recurrence and Lung Metastasis via Notch and Wnt/β-Catenin Signaling  Hua Jin, Song Luo, Yun Wang, Chang Liu, Zhenghao.
Volume 67, Issue 3, Pages e7 (August 2017)
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Volume 39, Issue 3, Pages (September 2013)
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang  Molecular Therapy 
Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma  Muneyoshi Futami, Kota Sato, Kanji Miyazaki, Kenshi.
Molecular Therapy - Nucleic Acids
Volume 25, Issue 4, Pages (April 2017)
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Molecular Therapy - Nucleic Acids
LncRNA TRERNA1 Function as an Enhancer of SNAI1 Promotes Gastric Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition  Huazhang Wu, Ying.
Long Noncoding RNA BC as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3  Jiaxin Lin, Xin Tan,
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 11, Issue 6, Pages (December 2018)
Molecular Therapy - Nucleic Acids
The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2  Cheng-Cao Sun, Ling Zhang, Guang.
Molecular Therapy - Nucleic Acids
Volume 23, Issue 4, Pages (April 2015)
MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling  Kai You, Song-Yang Li, Jiao Gong, Jian-Hong Fang,
MiR-431-5p directly targets RAF1 and is negatively correlated to RAF1 expression (A) The predicted binding sites of miR-431-5p and RAF1 3′-UTR, and mutant.
Molecular Therapy - Nucleic Acids
Volume 22, Issue 9, Pages (September 2014)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Molecular Therapy - Nucleic Acids
Volume 24, Issue 10, Pages (October 2016)
Volume 26, Issue 9, Pages (September 2018)
Molecular Therapy - Nucleic Acids
B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma  Jinhua Wang, Kelly K. Chong, Yoshitaka Nakamura, Linhda.
Molecular Therapy - Nucleic Acids
Presentation transcript:

miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin Chen, Yameng Xu, Shunchang Jiao  Molecular Therapy - Nucleic Acids  Volume 13, Pages 154-163 (December 2018) DOI: 10.1016/j.omtn.2018.08.020 Copyright © 2018 The Authors Terms and Conditions

Figure 1 SPIN1 Is Closely Correlated with Clinical Prognosis in NSCLC Patients (A) Representative immunohistochemistry images of SPIN1 expression in human lung cancer tissues and adjacent tissues. Scale bars, 150 μm (left) and 50 μm (right). (B) SPIN1 expression scores in lung cancer tissues and matched adjacent tissues (n = 85) were compared with the Mann-Whitney U test. (C) Kaplan-Meier survival curves and log rank tests were used to compare overall survival (OS) of NSCLC patients with low and high scores for SPIN1. (D) Kaplan-Meier survival curves and log rank tests were used to compare disease-free survival (DFS) of NSCLC patients with low and high scores for SPIN1. Molecular Therapy - Nucleic Acids 2018 13, 154-163DOI: (10.1016/j.omtn.2018.08.020) Copyright © 2018 The Authors Terms and Conditions

Figure 2 miR-409 Inhibits SPIN1 Expression by Targeting its 3′ UTR (A–D) Immunoblot analysis of the indicated NSCLC cell lines transfected with miR-409 (A and B) or anti-miR-409 (C and D). The histograms on the left of the immunoblots show the corresponding miR-409 mRNA expression levels. (E) miRNA luciferase reporter assays in A549 and H460 cells co-transfected with wild-type or mutated SPIN1 reporters and miR-409. Top: wild-type and mutant forms of putative miR-409 target sequences in the 3′ UTR of SPIN1. Bold and italicized fonts indicate putative miR-409-binding sites in the 3′ UTR of SPIN1. Underlining indicates mutations introduced into the 3′ UTR of SPIN1. (F) miRNA luciferase reporter assays in A549 and H460 cells co-transfected with wild-type or mutated SPIN1 reporters and anti-miR-409. Each bar represents the mean ± SD of at least three independent experiments performed in triplicate. *p < 0.05, **p < 0.01. Molecular Therapy - Nucleic Acids 2018 13, 154-163DOI: (10.1016/j.omtn.2018.08.020) Copyright © 2018 The Authors Terms and Conditions

Figure 3 miR-409 Inhibits NSCLC Cell Migration, Growth, and Proliferation through Inhibition of SPIN1 (A and B) Wound healing assays were conducted in A549 cells transfected with miR-409 or miR-409 and SPIN1 (A) or miR-409 inhibitor (B). Cell migration was measured 24 hr after the cell layers were scratched. (C and D) A549 cells expressing miR-409 or miR-409 and SPIN1 (C) and A549 cells transfected with miR-409 inhibitor (D) were cultured in regular medium. At the specified times, cell numbers were determined with the CCK-8 assay. The representative immunoblot shows SPIN1 expression. (E and F) A549 cells transfected with miR-409 (E) or miR-409 inhibitor (F) were plated and assayed for colony formation after 3 weeks. Representative images show colonies in plates (left). Each bar represents the mean ± SD of at least three independent experiments performed in triplicate. *p < 0.05. Molecular Therapy - Nucleic Acids 2018 13, 154-163DOI: (10.1016/j.omtn.2018.08.020) Copyright © 2018 The Authors Terms and Conditions

Figure 4 miR-409 Inhibits the Initiation of NSCLC (A and B) Stable A549 cells overexpressing miR-409 and miR-409 and SPIN1 were injected into nude mice (A). At the indicated times, tumors were measured with Vernier calipers (mean ± SD, n = 6) (B). (C and D) Bioluminescence imaging of metastasis of NSCLC cells in non-obese diabetic (NOD)-SCID mice 28 days after intravenous injection of cells infected with PCDH-control, PCDH-miR-409, or PCDH-miR-409 and SPIN1 via the lateral tail vein (C). The luminescence signal is represented by an overlaid false-color image, with the signal intensity indicated by the scale (D). (E and F) Representative foci of lungs were subjected to histological analyses (E). The data are shown as the mean ± SD (n = 6) (F). Molecular Therapy - Nucleic Acids 2018 13, 154-163DOI: (10.1016/j.omtn.2018.08.020) Copyright © 2018 The Authors Terms and Conditions

Figure 5 miR-409 Expression in Human NSCLC and the Correlation between miR-409 and SPIN1 (A) The expression of miR-409 in NSCLC tissues and matched adjacent tissues (n = 85) was compared using the Mann-Whitney U test. U6 small nuclear RNA was used as the internal control. (B) Kaplan-Meier survival curves and log rank tests were used to compare OS of NSCLC patients with high and low expression levels of miR-409. (C) Kaplan-Meier survival curves and log rank tests were used to compare the DFS of NSCLC patients with high and low expression levels of miR-409. (D) The relationship between miR-409 and SPIN1 expression based on western blot and immunohistochemistry assay was assessed by Spearman’s rank correlation analysis in NSCLC samples. The symbols represent individual samples. Molecular Therapy - Nucleic Acids 2018 13, 154-163DOI: (10.1016/j.omtn.2018.08.020) Copyright © 2018 The Authors Terms and Conditions